Papel de la quimioterapia en la secuenciación del cáncer de próstata - page 34

AR targeted therapy vs cabazitaxel in post-

docdetaxel setting

Maines F, et al .Crit Rev Oncol Hematol 2015

76.4% OS 12-m

61.3% OS 12-m

28.5% OS 12-m

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,24,25,26,27,28,29,30,31,32,33 35,36,37,38,39,40,41